The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Pre-Op Intra-Aortic Balloon Pumps Improve Coronary Artery Bypass Grafting Results
February 25th 2014Though most studies on the preoperative use of intra-aortic balloon pumps in coronary artery bypass grafting patients have reported early results, they have not been able to determine long-term outcomes.
Hospitals With Pricing Power Don't Necessarily Provide High-Quality Care
February 20th 2014Among hospitals with solid income streams, one might expect the quality of care to be high. However, postsurgical mortality rates and patient-safety indicators showed high-price hospitals perform worse on inpatient care quality than low-price facilities.
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
In Patients Hospitalized for Heart Failure, Hyponatremia Predicts Complications, But Not Mortality
February 18th 2014In a real-world sample of patients hospitalized for heart failure (HF), hyponatremia predicted clinical complications during admission, but it was not linked to short-term mortality or readmission.
Blood Pressure Drug Improves Functional Status of Peripheral Artery Disease Patients
February 5th 2014Among patients with peripheral artery disease and intermittent claudication, a daily dose of 10 mg ramipril can improve pain-free treadmill walking times, which are associated with a significant increase in physical functioning.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.